(Q43890481)

27 November 2017

title

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin and tetracycline in Lebanon (English)

1 reference

27 November 2017

0 references

1 reference

1 reference

1 reference

1 reference

1 reference

Ala I Sharara

1

1 reference

27 November 2017

Marwan Chedid

2

1 reference

27 November 2017

George F Araj

3

1 reference

27 November 2017

Kassem A Barada

4

1 reference

27 November 2017

Fadi H Mourad

5

1 reference

27 November 2017

publication date

1 February 2002

1 reference

International Journal of Antimicrobial Agents

27 November 2017

published in

1 reference

27 November 2017

volume

19

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

155-158

1 reference

Evidence for the essential role of Helicobacter pylori in gastric ulcer disease

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Clinical economics review: Helicobacter pylori-associated peptic ulcer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Peptic ulcer and Helicobacter pylori: eradication and relapse.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Evolution of metronidazole and tetracycline susceptibility pattern in Helicobacter pylori at a hospital in Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Effect of two different doses of metronidazole and tetracycline in bismuth triple therapy on eradication of Helicobacter pylori and its resistant strains

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Antimicrobial susceptibility test of Helicobacter pylori isolated from Jos, Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Metronidazole and clarithromycin susceptibility and the subtypes of vacA of Helicobacter pylori isolates in Estonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Prevalence and demographic determinants of metronidazole resistance by Helicobacter pylori in a large cosmopolitan cohort of Australian dyspeptic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

10.1016/S0924-8579(01)00482-4

Identifiers

DOI

1 reference

27 November 2017

1 reference